95. Nat Genet. 2018 Jun 18. doi: 10.1038/s41588-018-0132-x. [Epub ahead of print]A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer.Wu L(1), Shi W(2), Long J(1), Guo X(1), Michailidou K(3)(4), Beesley J(2), Bolla MK(3), Shu XO(1), Lu Y(1), Cai Q(1), Al-Ejeh F(2), Rozali E(2), Wang Q(3), DennisJ(3), Li B(5), Zeng C(1), Feng H(6)(7), Gusev A(8)(9)(10), Barfield RT(6),Andrulis IL(11)(12), Anton-Culver H(13), Arndt V(14), Aronson KJ(15), AuerPL(16)(17), Barrdahl M(18), Baynes C(19), Beckmann MW(20), Benitez J(21)(22),Bermisheva M(23)(24), Blomqvist C(25)(26), Bogdanova NV(24)(27)(28), BojesenSE(29)(30)(31), Brauch H(32)(33)(34), Brenner H(14)(34)(35), Brinton L(36),Broberg P(37), Brucker SY(38), Burwinkel B(39)(40), Caldés T(41), Canzian F(42), Carter BD(43), Castelao JE(44), Chang-Claude J(18)(45), Chen X(2), Cheng TD(46), Christiansen H(27), Clarke CL(47); NBCS Collaborators, Collée M(48), Cornelissen S(49), Couch FJ(50), Cox D(51)(52), Cox A(53), Cross SS(54), Cunningham JM(50),Czene K(55), Daly MB(56), Devilee P(57)(58), Doheny KF(59), Dörk T(24),Dos-Santos-Silva I(60), Dumont M(61), Dwek M(62), Eccles DM(63), Eilber U(18),Eliassen AH(7)(64), Engel C(65), Eriksson M(55), Fachal L(19), FaschingPA(20)(66), Figueroa J(36)(67), Flesch-Janys D(68)(69), Fletcher O(70), FlygerH(71), Fritschi L(72), Gabrielson M(55), Gago-Dominguez M(73)(74), GapsturSM(43), García-Closas M(36), Gaudet MM(43), Ghoussaini M(19), Giles GG(75)(76),Goldberg MS(77)(78), Goldgar DE(79), González-Neira A(21), Guénel P(80), HahnenE(81)(82)(83), Haiman CA(84), Håkansson N(85), Hall P(55)(86), Hallberg E(87),Hamann U(88), Harrington P(19), Hein A(20), Hicks B(89), Hillemanns P(24),Hollestelle A(90), Hoover RN(36), Hopper JL(76), Huang G(88), Humphreys K(55),Hunter DJ(7)(91), Jakubowska A(92)(93), Janni W(94), John EM(95)(96)(97), JohnsonN(70), Jones K(89), Jones ME(98), Jung A(18), Kaaks R(18), Kerin MJ(99),Khusnutdinova E(97)(100), Kosma VM(101)(102)(103), Kristensen VN(104)(105)(106), Lambrechts D(107)(108), Le Marchand L(109), Li J(110), Lindström S(111)(112),Lissowska J(113), Lo WY(32)(33), Loibl S(114), Lubinski J(90), Luccarini C(19),Lux MP(20), MacInnis RJ(75)(76), Maishman T(115), Kostovska IM(24)(116),Mannermaa A(101)(102)(103), Manson JE(7)(117), Margolin S(118), Mavroudis D(119),Meijers-Heijboer H(120), Meindl A(121), Menon U(122), Meyer J(50), MulliganAM(123)(124), Neuhausen SL(125), Nevanlinna H(126), Neven P(127), NielsenSF(29)(30), Nordestgaard BG(29)(30)(31), Olopade OI(128), Olson JE(87), OlssonH(37), Peterlongo P(129), Peto J(60), Plaseska-Karanfilska D(116), PrenticeR(16), Presneau N(62), Pylkäs K(130)(131), Rack B(94), Radice P(132), RahmanN(133), Rennert G(134), Rennert HS(134), Rhenius V(19), Romero A(41)(135), RommJ(59), Rudolph A(18), Saloustros E(136), Sandler DP(137), Sawyer EJ(138), SchmidtMK(49)(139), Schmutzler RK(81)(82)(83), Schneeweiss A(39)(140), ScottRJ(141)(142), Scott CG(87), Seal S(133), Shah M(19), Shrubsole MJ(1), SmeetsA(127), Southey MC(143), Spinelli JJ(144)(145), Stone J(146)(147), SurowyH(39)(40), Swerdlow AJ(98)(148), Tamimi RM(6)(7)(64), Tapper W(63), TaylorJA(137)(149), Terry MB(150), Tessier DC(151), Thomas A(87), Thöne K(45),Tollenaar RAEM(152), Torres D(88)(153), Truong T(80), Untch M(154), Vachon C(87),Van Den Berg D(84), Vincent D(151), Waisfisz Q(131), Weinberg CR(155), WendtC(118), Whittemore AS(96)(97), Wildiers H(127), Willett WC(7)(64)(156), Winqvist R(130)(131), Wolk A(85), Xia L(84), Yang XR(36), Ziogas A(13), Ziv E(157);kConFab/AOCS Investigators, Dunning AM(19), Pharoah PDP(3)(19), Simard J(61),Milne RL(75)(76), Edwards SL(2), Kraft P(6)(7), Easton DF(3)(19), Chenevix-TrenchG(158), Zheng W(159).Author information: (1)Division of Epidemiology, Department of Medicine, Vanderbilt EpidemiologyCenter, Vanderbilt-Ingram Cancer Center, Vanderbilt University School ofMedicine, Nashville, TN, USA.(2)Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane,Queensland, Australia.(3)Centre for Cancer Genetic Epidemiology, Department of Public Health andPrimary Care, University of Cambridge, Cambridge, UK.(4)Department of Electron Microscopy/Molecular Pathology, The Cyprus Institute ofNeurology and Genetics, Nicosia, Cyprus.(5)Department of Molecular Physiology & Biophysics, Vanderbilt GeneticsInstitute, Vanderbilt University, Nashville, TN, USA.(6)Program in Genetic Epidemiology and Statistical Genetics, Harvard T.H. ChanSchool of Public Health, Boston, MA, USA.(7)Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston,MA, USA.(8)Department of Medical Oncology, Dana Farber Cancer Institute, Boston, MA, USA.(9)Department of Medicine, Harvard Medical School, Boston, MA, USA.(10)Division of Genetics, Brigham and Women's Hospital, Boston, MA, USA.(11)Fred A. Litwin Center for Cancer Genetics, Lunenfeld-Tanenbaum ResearchInstitute of Mount Sinai Hospital, Toronto, Ontario, Canada.(12)Department of Molecular Genetics, University of Toronto, Toronto, Ontario,Canada.(13)Department of Epidemiology, University of California Irvine, Irvine, CA, USA.(14)Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg, Germany.(15)Department of Public Health Sciences, and Cancer Research Institute, Queen's University, Kingston, Ontario, Canada.(16)Cancer Prevention Program, Fred Hutchinson Cancer Research Center, Seattle,WA, USA.(17)Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee,WI, USA.(18)Division of Cancer Epidemiology, German Cancer Research Center (DKFZ),Heidelberg, Germany.(19)Centre for Cancer Genetic Epidemiology, Department of Oncology, University ofCambridge, Cambridge, UK.(20)Department of Gynaecology and Obstetrics, University Hospital Erlangen,Friedrich-Alexander University Erlangen-Nuremberg, Comprehensive Cancer CenterErlangen-EMN, Erlangen, Germany.(21)Human Cancer Genetics Program, Spanish National Cancer Research Centre,Madrid, Spain.(22)Centro de Investigación en Red de Enfermedades Raras (CIBERER), Valencia,Spain.(23)Institute of Biochemistry and Genetics, Ufa Scientific Center of RussianAcademy of Sciences, Ufa, Russia.(24)Gynaecology Research Unit, Hannover Medical School, Hannover, Germany.(25)Department of Oncology, Helsinki University Hospital, University of Helsinki,Helsinki, Finland.(26)Department of Oncology, University of Örebro, Örebro, Sweden.(27)Department of Radiation Oncology, Hannover Medical School, Hannover, Germany.(28)N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.(29)Copenhagen General Population Study, Herlev and Gentofte Hospital, CopenhagenUniversity Hospital, Herlev, Denmark.(30)Department of Clinical Biochemistry, Herlev and Gentofte Hospital, CopenhagenUniversity Hospital, Herlev, Denmark.(31)Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen,Denmark.(32)Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart,Germany.(33)University of Tübingen, Tübingen, Germany.(34)German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ),Heidelberg, Germany.(35)Division of Preventive Oncology, German Cancer Research Center (DKFZ) andNational Center for Tumor Diseases (NCT), Heidelberg, Germany.(36)Division of Cancer Epidemiology and Genetics, National Cancer Institute,Rockville, MD, USA.(37)Department of Cancer Epidemiology, Clinical Sciences, Lund University, Lund, Sweden.(38)Department of Gynecology and Obstetrics, University of Tübingen, Tübingen,Germany.(39)Department of Obstetrics and Gynecology, University of Heidelberg,Heidelberg, Germany.(40)Molecular Epidemiology Group, C080, German Cancer Research Center (DKFZ),Heidelberg, Germany.(41)Medical Oncology Department, CIBERONC Hospital Clínico San Carlos, Madrid,Spain.(42)Genomic Epidemiology Group, German Cancer Research Center (DKFZ), Heidelberg,Germany.(43)Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.(44)Oncology and Genetics Unit, Instituto de Investigacion Biomedica Galicia Sur (IISGS), Xerencia de Xestion Integrada de Vigo-SERGAS, Vigo, Spain.(45)University Cancer Center Hamburg (UCCH), University Medical CenterHamburg-Eppendorf, Hamburg, Germany.(46)Department of Epidemiology, University of Florida, Gainesville, FL, USA.(47)Westmead Institute for Medical Research, University of Sydney, Sydney, NewSouth Wales, Australia.(48)Department of Clinical Genetics, Erasmus University Medical Center,Rotterdam, The Netherlands.(49)Division of Molecular Pathology, The Netherlands Cancer Institute - Antonivan Leeuwenhoek Hospital, Amsterdam, The Netherlands.(50)Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.(51)Department of Epidemiology and Biostatistics, School of Public Health,Imperial College London, London, UK.(52)INSERM U1052, Cancer Research Center of Lyon, Lyon, France.(53)Sheffield Institute for Nucleic Acids, Department of Oncology and Metabolism,University of Sheffield, Sheffield, UK.(54)Academic Unit of Pathology, Department of Neuroscience, University ofSheffield, Sheffield, UK.(55)Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.(56)Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, PA,USA.(57)Department of Pathology, Leiden University Medical Center, Leiden, TheNetherlands.(58)Department of Human Genetics, Leiden University Medical Center, Leiden, TheNetherlands.(59)Center for Inherited Disease Research (CIDR), Institute of Genetic Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.(60)Department of Non-Communicable Disease Epidemiology, London School of Hygieneand Tropical Medicine, London, UK.(61)Genomics Center, Centre Hospitalier Universitaire de Québec - UniversitéLaval Research Center, Québec City, QC, Canada.(62)Department of Biomedical Sciences, Faculty of Science and Technology,University of Westminster, London, UK.(63)Cancer Sciences Academic Unit, Faculty of Medicine, University ofSouthampton, Southampton, UK.(64)Channing Division of Network Medicine, Department of Medicine, Brigham andWomen's Hospital, Harvard Medical School, Boston, MA, USA.(65)Institute for Medical Informatics, Statistics and Epidemiology, University ofLeipzig, Leipzig, Germany.(66)David Geffen School of Medicine, Department of Medicine Division ofHematology and Oncology, University of California at Los Angeles, Los Angeles,CA, USA.(67)Usher Institute of Population Health Sciences and Informatics, The Universityof Edinburgh Medical School, Edinburgh, UK.(68)Institute for Medical Biometrics and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.(69)Department of Cancer Epidemiology, Clinical Cancer Registry, UniversityMedical Center Hamburg-Eppendorf, Hamburg, Germany.(70)The Breast Cancer Now Toby Robins Research Centre, The Institute of CancerResearch, London, UK.(71)Department of Breast Surgery, Herlev and Gentofte Hospital, CopenhagenUniversity Hospital, Herlev, Denmark.(72)School of Public Health, Curtin University, Perth, Western Australia,Australia.(73)Genomic Medicine Group, Galician Foundation of Genomic Medicine, Instituto deInvestigación Sanitaria de Santiago de Compostela (IDIS), Complejo HospitalarioUniversitario de Santiago, SERGAS, Santiago De Compostela, Spain.(74)Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.(75)Cancer Epidemiology & Intelligence Division, Cancer Council Victoria,Melbourne, Victoria, Australia.(76)Centre for Epidemiology and Biostatistics, Melbourne School of Population andGlobal Health, The University of Melbourne, Melbourne, Victoria, Australia.(77)Department of Medicine, McGill University, Montréal, Quebec, Canada.(78)Division of Clinical Epidemiology, Royal Victoria Hospital, McGillUniversity, Montréal, Quebec, Canada.(79)Department of Dermatology, Huntsman Cancer Institute, University of UtahSchool of Medicine, Salt Lake City, UT, USA.(80)Cancer & Environment Group, Center for Research in Epidemiology andPopulation Health (CESP), INSERM, University Paris-Sud, University Paris-Saclay, Villejuif, France.(81)Center for Hereditary Breast and Ovarian Cancer, University Hospital ofCologne, Cologne, Germany.(82)Center for Integrated Oncology (CIO), University Hospital of Cologne,Cologne, Germany.(83)Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne,Germany.(84)Department of Preventive Medicine, Keck School of Medicine, University ofSouthern California, Los Angeles, CA, USA.(85)Institute of Environmental Medicine, Karolinska Institutet, Stockholm,Sweden.(86)Department of Oncology, Södersjukhuset, Stockholm, Sweden.(87)Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA.(88)Molecular Genetics of Breast Cancer, German Cancer Research Center (DKFZ),Heidelberg, Germany.(89)Cancer Genomics Research Laboratory, Leidos Biomedical Research, FrederickNational Laboratory for Cancer Research, Frederick, MD, USA.(90)Department of Medical Oncology, Family Cancer Clinic, Erasmus MC CancerInstitute, Rotterdam, The Netherlands.(91)Nuffield Department of Population Health, University of Oxford, Big DataInstitute, Oxford, UK.(92)Department of Genetics and Pathology, Pomeranian Medical University,Szczecin, Poland.(93)Independent Laboratory of Molecular Biology and Genetic Diagnostics,Pomeranian Medical University, Szczecin, Poland.(94)Department of Gynecology and Obstetrics, University Hospital Ulm, Ulm,Germany.(95)Department of Epidemiology, Cancer Prevention Institute of California,Fremont, CA, USA.(96)Department of Health Research and Policy - Epidemiology, Stanford University School of Medicine, Stanford, CA, USA.(97)Stanford Cancer Institute, Stanford University School of Medicine, Stanford, CA, USA.(98)Division of Genetics and Epidemiology, The Institute of Cancer Research,London, UK.(99)School of Medicine, National University of Ireland, Galway, Ireland.(100)Department of Genetics and Fundamental Medicine, Bashkir State University,Ufa, Russia.(101)Translational Cancer Research Area, University of Eastern Finland, Kuopio,Finland.(102)Institute of Clinical Medicine, Pathology and Forensic Medicine, University of Eastern Finland, Kuopio, Finland.(103)Imaging Center, Department of Clinical Pathology, Kuopio UniversityHospital, Kuopio, Finland.(104)Department of Cancer Genetics, Institute for Cancer Research, OsloUniversity Hospital Radiumhospitalet, Oslo, Norway.(105)Institute of Clinical Medicine, Faculty of Medicine, University of Oslo,Oslo, Norway.(106)Department of Clinical Molecular Biology, Oslo University Hospital,University of Oslo, Oslo, Norway.(107)VIB KULeuven Center for Cancer Biology, VIB, Leuven, Belgium.(108)Laboratory for Translational Genetics, Department of Human Genetics, KULeuven, Leuven, Belgium.(109)Epidemiology Program, University of Hawaii Cancer Center, Honolulu, HI, USA.(110)Human Genetics, Genome Institute of Singapore, Singapore, Singapore.(111)Department of Epidemiology, University of Washington School of PublicHealth, Seattle, WA, USA.(112)Public Health Sciences Division, Fred Hutchinson Cancer Research Center,Seattle, WA, USA.(113)Department of Cancer Epidemiology and Prevention, M. Sklodowska-CurieInstitute - Oncology Center, Warsaw, Poland.(114)German Breast Group, GmbH, Neu Isenburg, Germany.(115)Southampton Clinical Trials Unit, University of Southampton, Southampton,UK.(116)Research Centre for Genetic Engineering and Biotechnology "Georgi D.Efremov", Macedonian Academy of Sciences and Arts, Skopje, Macedonia.(117)Department of Medicine, Brigham and Women's Hospital, Harvard MedicalSchool, Boston, MA, USA.(118)Department of Oncology - Pathology, Karolinska Institutet, Stockholm,Sweden.(119)Department of Medical Oncology, University Hospital of Heraklion, Heraklion,Greece.(120)Department of Clinical Genetics, VU University Medical Center, Amsterdam,The Netherlands.(121)Division of Gynaecology and Obstetrics, Technische Universität München,Munich, Germany.(122)Gynaecological Cancer Research Centre, Women's Cancer, Institute for Women'sHealth, University College London, London, UK.(123)Department of Laboratory Medicine and Pathobiology, University of Toronto,Toronto, Ontario, Canada.(124)Laboratory Medicine Program, University Health Network, Toronto, Ontario,Canada.(125)Department of Population Sciences, Beckman Research Institute of City ofHope, Duarte, CA, USA.(126)Department of Obstetrics and Gynecology, Helsinki University Hospital,University of Helsinki, Helsinki, Finland.(127)Leuven Multidisciplinary Breast Center, Department of Oncology, LeuvenCancer Institute, University Hospitals Leuven, Leuven, Belgium.(128)Center for Clinical Cancer Genetics and Global Health, The University ofChicago, Chicago, IL, USA.(129)IFOM, The FIRC (Italian Foundation for Cancer Research) Institute ofMolecular Oncology, Milan, Italy.(130)Laboratory of Cancer Genetics and Tumor Biology, Cancer and TranslationalMedicine Research Unit, Biocenter Oulu, University of Oulu, Oulu, Finland.(131)Laboratory of Cancer Genetics and Tumor Biology, Northern Finland LaboratoryCentre Oulu, Oulu, Finland.(132)Unit of Molecular Bases of Genetic Risk and Genetic Testing, Department ofResearch, Fondazione IRCCS (Istituto Di Ricovero e Cura a Carattere Scientifico) Istituto Nazionale dei Tumori (INT), Milan, Italy.(133)Section of Cancer Genetics, The Institute of Cancer Research, London, UK.(134)Department of Community Medicine and Epidemiology, Carmel Medical Center,Ruth and Bruce Rappaport Faculty of Medicine, Technion-Israel Institute ofTechnology and Clalit National Cancer Control Center, Haifa, Israel.(135)Medical Oncology Department, Hospital Universitario Puerta de Hierro,Madrid, Spain.(136)Hereditary Cancer Clinic, University Hospital of Heraklion, Heraklion,Greece.(137)Epidemiology Branch, National Institute of Environmental Health Sciences,NIH, Research Triangle Park, NC, USA.(138)Research Oncology, Guy's Hospital, King's College London, London, UK.(139)Division of Psychosocial Research and Epidemiology, The Netherlands CancerInstitute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.(140)National Center for Tumor Diseases, University of Heidelberg, Heidelberg,Germany.(141)Division of Molecular Medicine, Pathology North, John Hunter Hospital,Newcastle, New South Wales, Australia.(142)Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, Faculty of Health, University of Newcastle, Newcastle, New South Wales,Australia.(143)Department of Pathology, The University of Melbourne, Melbourne, Victoria,Australia.(144)Cancer Control Research, BC Cancer Agency, Vancouver, British Columbia,Canada.(145)School of Population and Public Health, University of British Columbia,Vancouver, British Columbia, Canada.(146)The Curtin UWA Centre for Genetic Origins of Health and Disease, CurtinUniversity and University of Western Australia, Perth, Western Australia,Australia.(147)Department of Obstetrics and Gynaecology, University of Melbourne and theRoyal Women's Hospital, Melbourne, Victoria, Australia.(148)Division of Breast Cancer Research, The Institute of Cancer Research,London, UK.(149)Epigenetic and Stem Cell Biology Laboratory, National Institute ofEnvironmental Health Sciences, NIH, Research Triangle Park, NC, USA.(150)Department of Epidemiology, Mailman School of Public Health, ColumbiaUniversity, New York, NY, USA.(151)McGill University and Génome Québec Innovation Centre, Montréal, Quebec,Canada.(152)Department of Surgery, Leiden University Medical Center, Leiden, TheNetherlands.(153)Institute of Human Genetics, Pontificia Universidad Javeriana, Bogota,Colombia.(154)Department of Gynecology and Obstetrics, Helios Clinics Berlin-Buch, Berlin,Germany.(155)Biostatistics and Computational Biology Branch, National Institute ofEnvironmental Health Sciences, NIH, Research Triangle Park, NC, USA.(156)Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA, USA.(157)Department of Medicine, Institute for Human Genetics, UCSF Helen DillerFamily Comprehensive Cancer Center, University of California San Francisco, SanFrancisco, CA, USA.(158)Cancer Division, QIMR Berghofer Medical Research Institute, Brisbane,Queensland, Australia. Georgia.Trench@qimrberghofer.edu.au.(159)Division of Epidemiology, Department of Medicine, Vanderbilt EpidemiologyCenter, Vanderbilt-Ingram Cancer Center, Vanderbilt University School ofMedicine, Nashville, TN, USA. wei.zheng@vanderbilt.edu.The breast cancer risk variants identified in genome-wide association studiesexplain only a small fraction of the familial relative risk, and the genesresponsible for these associations remain largely unknown. To identify novel riskloci and likely causal genes, we performed a transcriptome-wide association studyevaluating associations of genetically predicted gene expression with breastcancer risk in 122,977 cases and 105,974 controls of European ancestry. We useddata from the Genotype-Tissue Expression Project to establish genetic models topredict gene expression in breast tissue and evaluated model performance usingdata from The Cancer Genome Atlas. Of the 8,597 genes evaluated, significantassociations were identified for 48 at a Bonferroni-corrected threshold ofP < 5.82 × 10-6, including 14 genes at loci not yet reported for breast cancer.We silenced 13 genes and showed an effect for 11 on cell proliferation and/orcolony-forming efficiency. Our study provides new insights into breast cancergenetics and biology.DOI: 10.1038/s41588-018-0132-x PMID: 29915430 